盘后时段
|
||||
|
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
4.06/5.24
|
|
企业价值
9.19B
|
| 资产负债 |
|
每股账面净值
36.21
|
| 现金流量 |
|
现金流量率
0.10
|
| 损益表 |
|
收益
2.94B
|
|
每股收益
9.26
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but vaulted its market share in 2023 through a merger with former competitor NuVasive. In 2025, the company acquired Nevro, a smaller player that specialized in spinal cord stimulation therapy. Globus Medical reports two business segments, musculoskeletal solutions and enabling technologies, which consist of implants used in surgery and associated technologies that assist the physician. |

67.99 

66.89